A Japanese biopharma company working on a tooth regeneration medication just raised millions for a Phase 2 clinical trial.
The neurologist Orlando Swayne doesn’t suggest everyone can recover. But he does argue that early, targeted and intense therapy can sometimes bring about life-changing improvements – and we have a mor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results